UniProt ID | ABL2_HUMAN | |
---|---|---|
UniProt AC | P42684 | |
Protein Name | Tyrosine-protein kinase ABL2 | |
Gene Name | ABL2 | |
Organism | Homo sapiens (Human). | |
Sequence Length | 1182 | |
Subcellular Localization | Cytoplasm, cytoskeleton. | |
Protein Description | Non-receptor tyrosine-protein kinase that plays an ABL1-overlapping role in key processes linked to cell growth and survival such as cytoskeleton remodeling in response to extracellular stimuli, cell motility and adhesion and receptor endocytosis. Coordinates actin remodeling through tyrosine phosphorylation of proteins controlling cytoskeleton dynamics like MYH10 (involved in movement); CTTN (involved in signaling); or TUBA1 and TUBB (microtubule subunits). Binds directly F-actin and regulates actin cytoskeletal structure through its F-actin-bundling activity. Involved in the regulation of cell adhesion and motility through phosphorylation of key regulators of these processes such as CRK, CRKL, DOK1 or ARHGAP35. Adhesion-dependent phosphorylation of ARHGAP35 promotes its association with RASA1, resulting in recruitment of ARHGAP35 to the cell periphery where it inhibits RHO. Phosphorylates multiple receptor tyrosine kinases like PDGFRB and other substrates which are involved in endocytosis regulation such as RIN1. In brain, may regulate neurotransmission by phosphorylating proteins at the synapse. ABL2 acts also as a regulator of multiple pathological signaling cascades during infection. Pathogens can highjack ABL2 kinase signaling to reorganize the host actin cytoskeleton for multiple purposes, like facilitating intracellular movement and host cell exit. Finally, functions as its own regulator through autocatalytic activity as well as through phosphorylation of its inhibitor, ABI1.. | |
Protein Sequence | MGQQVGRVGEAPGLQQPQPRGIRGSSAARPSGRRRDPAGRTTETGFNIFTQHDHFASCVEDGFEGDKTGGSSPEALHRPYGCDVEPQALNEAIRWSSKENLLGATESDPNLFVALYDFVASGDNTLSITKGEKLRVLGYNQNGEWSEVRSKNGQGWVPSNYITPVNSLEKHSWYHGPVSRSAAEYLLSSLINGSFLVRESESSPGQLSISLRYEGRVYHYRINTTADGKVYVTAESRFSTLAELVHHHSTVADGLVTTLHYPAPKCNKPTVYGVSPIHDKWEMERTDITMKHKLGGGQYGEVYVGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTLEPPFYIVTEYMPYGNLLDYLRECNREEVTAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHVVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNTFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYDLLEKGYRMEQPEGCPPKVYELMRACWKWSPADRPSFAETHQAFETMFHDSSISEEVAEELGRAASSSSVVPYLPRLPILPSKTRTLKKQVENKENIEGAQDATENSASSLAPGFIRGAQASSGSPALPRKQRDKSPSSLLEDAKETCFTRDRKGGFFSSFMKKRNAPTPPKRSSSFREMENQPHKKYELTGNFSSVASLQHADGFSFTPAQQEANLVPPKCYGGSFAQRNLCNDDGGGGGGSGTAGGGWSGITGFFTPRLIKKTLGLRAGKPTASDDTSKPFPRSNSTSSMSSGLPEQDRMAMTLPRNCQRSKLQLERTVSTSSQPEENVDRANDMLPKKSEESAAPSRERPKAKLLPRGATALPLRTPSGDLAITEKDPPGVGVAGVAAAPKGKEKNGGARLGMAGVPEDGEQPGWPSPAKAAPVLPTTHNHKVPVLISPTLKHTPADVQLIGTDSQGNKFKLLSEHQVTSSGDKDRPRRVKPKCAPPPPPVMRLLQHPSICSDPTEEPTALTAGQSTSETQEGGKKAALGAVPISGKAGRPVMPPPQVPLPTSSISPAKMANGTAGTKVALRKTKQAAEKISADKISKEALLECADLLSSALTEPVPNSQLVDTGHQLLDYCSGYVDCIPQTRNKFAFREAVSKLELSLQELQVSSAAAGVPGTNPVLNNLLSCVQEISDVVQR | |
Overview of Protein Modification Sites with Functional and Structural Information | ||
* ASA = Accessible Surface Area
Locations | Modification | Substrate Peptides & Secondary Structure |
ASA (%) | Reference | Orthologous Protein Cluster |
---|---|---|---|---|---|
2 | Myristoylation | ------MGQQVGRVG ------CCCCCCCCC | 37.62 | - | |
5 (in isoform 10) | Phosphorylation | - | 3.98 | 24043423 | |
5 (in isoform 2) | Phosphorylation | - | 3.98 | 24043423 | |
5 (in isoform 3) | Phosphorylation | - | 3.98 | 24043423 | |
5 (in isoform 4) | Phosphorylation | - | 3.98 | 24043423 | |
12 (in isoform 10) | Phosphorylation | - | 39.46 | 24043423 | |
12 (in isoform 2) | Phosphorylation | - | 39.46 | 24043423 | |
12 (in isoform 3) | Phosphorylation | - | 39.46 | 24043423 | |
12 (in isoform 4) | Phosphorylation | - | 39.46 | 24043423 | |
13 (in isoform 10) | Phosphorylation | - | 43.07 | 24043423 | |
13 (in isoform 2) | Phosphorylation | - | 43.07 | 24043423 | |
13 (in isoform 3) | Phosphorylation | - | 43.07 | 24043423 | |
13 (in isoform 4) | Phosphorylation | - | 43.07 | 24043423 | |
23 | Methylation | QPQPRGIRGSSAARP CCCCCCCCCCCCCCC | 41.59 | - | |
25 | Phosphorylation | QPRGIRGSSAARPSG CCCCCCCCCCCCCCC | 13.62 | 20068231 | |
26 | Phosphorylation | PRGIRGSSAARPSGR CCCCCCCCCCCCCCC | 28.86 | 20068231 | |
31 | Phosphorylation | GSSAARPSGRRRDPA CCCCCCCCCCCCCCC | 39.10 | 20068231 | |
57 | Phosphorylation | TQHDHFASCVEDGFE CCCCHHHHHHHCCCC | 20.11 | 32142685 | |
59 (in isoform 6) | Phosphorylation | - | 7.52 | 27307780 | |
59 (in isoform 7) | Phosphorylation | - | 7.52 | 27307780 | |
59 (in isoform 8) | Phosphorylation | - | 7.52 | 27307780 | |
60 (in isoform 2) | Phosphorylation | - | 57.66 | - | |
68 | Phosphorylation | DGFEGDKTGGSSPEA CCCCCCCCCCCCHHH | 52.06 | 25159151 | |
71 | Phosphorylation | EGDKTGGSSPEALHR CCCCCCCCCHHHHCC | 44.03 | 25159151 | |
72 | Phosphorylation | GDKTGGSSPEALHRP CCCCCCCCHHHHCCC | 29.99 | 25159151 | |
80 | Phosphorylation | PEALHRPYGCDVEPQ HHHHCCCCCCCCCHH | 30.28 | 18691976 | |
80 (in isoform 2) | Phosphorylation | - | 30.28 | - | |
96 | Phosphorylation | LNEAIRWSSKENLLG HHHHHHHHCCCCCCC | 22.99 | 18691976 | |
97 | Phosphorylation | NEAIRWSSKENLLGA HHHHHHHCCCCCCCC | 36.71 | 28464451 | |
107 | Phosphorylation | NLLGATESDPNLFVA CCCCCCCCCCCEEEE | 54.75 | 28464451 | |
116 | Phosphorylation | PNLFVALYDFVASGD CCEEEEEHHHHHCCC | 9.52 | 17192257 | |
121 | Phosphorylation | ALYDFVASGDNTLSI EEHHHHHCCCCEEEE | 41.18 | 20071362 | |
125 | Phosphorylation | FVASGDNTLSITKGE HHHCCCCEEEEECCC | 26.99 | 20068231 | |
127 | Phosphorylation | ASGDNTLSITKGEKL HCCCCEEEEECCCEE | 26.61 | 24719451 | |
139 | Phosphorylation | EKLRVLGYNQNGEWS CEEEEEEECCCCCCE | 14.93 | 19275932 | |
159 | Phosphorylation | NGQGWVPSNYITPVN CCCCEECCCCCCCCH | 32.42 | 21945579 | |
161 | Phosphorylation | QGWVPSNYITPVNSL CCEECCCCCCCCHHH | 15.54 | 21945579 | |
163 | Phosphorylation | WVPSNYITPVNSLEK EECCCCCCCCHHHCC | 15.72 | 21945579 | |
164 (in isoform 2) | Phosphorylation | - | 17.46 | - | |
167 | Phosphorylation | NYITPVNSLEKHSWY CCCCCCHHHCCCCCC | 37.83 | 18691976 | |
167 (in isoform 2) | Phosphorylation | - | 37.83 | - | |
172 | Phosphorylation | VNSLEKHSWYHGPVS CHHHCCCCCCCCCCC | 40.16 | 21945579 | |
172 (in isoform 2) | Phosphorylation | - | 40.16 | - | |
174 | Phosphorylation | SLEKHSWYHGPVSRS HHCCCCCCCCCCCHH | 10.42 | 21945579 | |
179 | Phosphorylation | SWYHGPVSRSAAEYL CCCCCCCCHHHHHHH | 24.53 | 21945579 | |
185 | Phosphorylation | VSRSAAEYLLSSLIN CCHHHHHHHHHHHHC | 14.28 | - | |
194 | Phosphorylation | LSSLINGSFLVRESE HHHHHCCCEEEEECC | 15.77 | - | |
195 (in isoform 2) | Phosphorylation | - | 8.51 | - | |
200 | Phosphorylation | GSFLVRESESSPGQL CCEEEEECCCCCCEE | 32.01 | 22496350 | |
202 | Phosphorylation | FLVRESESSPGQLSI EEEEECCCCCCEEEE | 51.62 | 29255136 | |
203 | Phosphorylation | LVRESESSPGQLSIS EEEECCCCCCEEEEE | 29.06 | 29255136 | |
208 | Phosphorylation | ESSPGQLSISLRYEG CCCCCEEEEEEEECC | 11.40 | 25159151 | |
210 | Phosphorylation | SPGQLSISLRYEGRV CCCEEEEEEEECCEE | 11.92 | 29496963 | |
213 | Phosphorylation | QLSISLRYEGRVYHY EEEEEEEECCEEEEE | 28.20 | 23917254 | |
218 | Phosphorylation | LRYEGRVYHYRINTT EEECCEEEEEEEEEC | 7.56 | 21447384 | |
224 | Phosphorylation | VYHYRINTTADGKVY EEEEEEEECCCCEEE | 22.46 | 28152594 | |
225 | Phosphorylation | YHYRINTTADGKVYV EEEEEEECCCCEEEE | 20.47 | 28152594 | |
231 | Phosphorylation | TTADGKVYVTAESRF ECCCCEEEEEEECHH | 8.79 | 25159151 | |
233 | Phosphorylation | ADGKVYVTAESRFST CCCEEEEEEECHHHH | 13.66 | 28152594 | |
236 | Phosphorylation | KVYVTAESRFSTLAE EEEEEEECHHHHHHH | 35.84 | 28152594 | |
236 (in isoform 2) | Phosphorylation | - | 35.84 | - | |
239 | Phosphorylation | VTAESRFSTLAELVH EEEECHHHHHHHHHH | 22.77 | 18691976 | |
239 (in isoform 2) | Phosphorylation | - | 22.77 | - | |
261 | Phosphorylation | GLVTTLHYPAPKCNK CCEEEEECCCCCCCC | 12.28 | 15735735 | |
270 | Phosphorylation | APKCNKPTVYGVSPI CCCCCCCCEEEECCC | 28.15 | 29978859 | |
272 | Phosphorylation | KCNKPTVYGVSPIHD CCCCCCEEEECCCCC | 17.81 | 16464493 | |
275 | Phosphorylation | KPTVYGVSPIHDKWE CCCEEEECCCCCCCE | 17.49 | 25159151 | |
277 (in isoform 2) | Phosphorylation | - | 5.23 | - | |
286 | Phosphorylation | DKWEMERTDITMKHK CCCEECCCEEEEEEE | 20.60 | 24719451 | |
289 | Phosphorylation | EMERTDITMKHKLGG EECCCEEEEEEECCC | 23.99 | - | |
299 | Phosphorylation | HKLGGGQYGEVYVGV EECCCCCCCEEEEEE | 20.66 | 19060867 | |
303 | Phosphorylation | GGQYGEVYVGVWKKY CCCCCEEEEEEEECE | 6.28 | 16464493 | |
310 | Phosphorylation | YVGVWKKYSLTVAVK EEEEEECEEEEEEEE | 12.75 | 12522270 | |
311 | Phosphorylation | VGVWKKYSLTVAVKT EEEEECEEEEEEEEC | 26.83 | 28152594 | |
313 | Phosphorylation | VWKKYSLTVAVKTLK EEECEEEEEEEECCC | 10.65 | 20068231 | |
320 | Acetylation | TVAVKTLKEDTMEVE EEEEECCCCCCHHHH | 59.79 | 19815467 | |
331 | Ubiquitination | MEVEEFLKEAAVMKE HHHHHHHHHHHHHHH | 51.10 | - | |
352 | Phosphorylation | VQLLGVCTLEPPFYI HHHHCEEECCCCEEE | 31.58 | 22210691 | |
358 | Phosphorylation | CTLEPPFYIVTEYMP EECCCCEEEEEECCC | 10.56 | 24043423 | |
361 | Phosphorylation | EPPFYIVTEYMPYGN CCCEEEEEECCCCCH | 16.31 | 22210691 | |
363 | Phosphorylation | PFYIVTEYMPYGNLL CEEEEEECCCCCHHH | 8.27 | 24043423 | |
366 | Phosphorylation | IVTEYMPYGNLLDYL EEEECCCCCHHHHHH | 11.34 | 24043423 | |
372 | Phosphorylation | PYGNLLDYLRECNRE CCCHHHHHHHHCCHH | 13.97 | 24043423 | |
388 | Phosphorylation | VTAVVLLYMATQISS HHHHHHHHHHHHHHH | 4.79 | 30377224 | |
391 | Phosphorylation | VVLLYMATQISSAME HHHHHHHHHHHHHHH | 15.20 | 22210691 | |
394 | Phosphorylation | LYMATQISSAMEYLE HHHHHHHHHHHHHHH | 11.39 | 22210691 | |
395 | Phosphorylation | YMATQISSAMEYLEK HHHHHHHHHHHHHHH | 33.01 | 22210691 | |
399 | Phosphorylation | QISSAMEYLEKKNFI HHHHHHHHHHHCCCC | 13.69 | 22210691 | |
402 (in isoform 2) | Phosphorylation | - | 50.88 | - | |
404 (in isoform 2) | Phosphorylation | - | 52.77 | - | |
410 | Ubiquitination | KNFIHRDLAARNCLV CCCCCHHHHHCCCCC | 3.96 | 22817900 | |
414 | Ubiquitination | HRDLAARNCLVGENH CHHHHHCCCCCCCCC | 20.81 | 22817900 | |
425 | Ubiquitination | GENHVVKVADFGLSR CCCCEEEEHHHCCCH | 4.11 | 22817900 | |
429 | Ubiquitination | VVKVADFGLSRLMTG EEEEHHHCCCHHCCC | 24.24 | 22817900 | |
431 | Ubiquitination | KVADFGLSRLMTGDT EEHHHCCCHHCCCCE | 24.61 | 22817900 | |
435 | Phosphorylation | FGLSRLMTGDTYTAH HCCCHHCCCCEEECC | 36.18 | 21945579 | |
435 | Ubiquitination | FGLSRLMTGDTYTAH HCCCHHCCCCEEECC | 36.18 | 22817900 | |
438 | Phosphorylation | SRLMTGDTYTAHAGA CHHCCCCEEECCCCC | 24.90 | 21945579 | |
439 | Phosphorylation | RLMTGDTYTAHAGAK HHCCCCEEECCCCCC | 13.48 | 22322096 | |
440 | Phosphorylation | LMTGDTYTAHAGAKF HCCCCEEECCCCCCC | 17.66 | 21945579 | |
446 | Ubiquitination | YTAHAGAKFPIKWTA EECCCCCCCCCEECC | 51.24 | 22817900 | |
450 | Ubiquitination | AGAKFPIKWTAPESL CCCCCCCEECCCCHH | 38.44 | 22817900 | |
452 | Phosphorylation | AKFPIKWTAPESLAY CCCCCEECCCCHHHC | 27.60 | - | |
459 | Phosphorylation | TAPESLAYNTFSIKS CCCCHHHCCCCCCCC | 21.74 | - | |
492 | Phosphorylation | PYPGIDLSQVYDLLE CCCCCCHHHHHHHHH | 17.53 | - | |
515 | Phosphorylation | EGCPPKVYELMRACW CCCCHHHHHHHHHHH | 14.96 | 12522270 | |
542 | Ubiquitination | THQAFETMFHDSSIS HHHHHHHHHCCCCCC | 1.90 | 29967540 | |
557 | Ubiquitination | EEVAEELGRAASSSS HHHHHHHHHHHHCCC | 22.06 | 29967540 | |
561 | Phosphorylation | EELGRAASSSSVVPY HHHHHHHHCCCCCCC | 29.75 | 28442448 | |
562 | Phosphorylation | ELGRAASSSSVVPYL HHHHHHHCCCCCCCC | 23.16 | 21945579 | |
563 | Phosphorylation | LGRAASSSSVVPYLP HHHHHHCCCCCCCCC | 25.34 | 21945579 | |
563 | Ubiquitination | LGRAASSSSVVPYLP HHHHHHCCCCCCCCC | 25.34 | 29967540 | |
563 (in isoform 2) | Phosphorylation | - | 25.34 | - | |
564 | Phosphorylation | GRAASSSSVVPYLPR HHHHHCCCCCCCCCC | 29.14 | 28442448 | |
566 (in isoform 2) | Phosphorylation | - | 2.52 | - | |
568 | Phosphorylation | SSSSVVPYLPRLPIL HCCCCCCCCCCCCCC | 20.09 | 21945579 | |
577 | Phosphorylation | PRLPILPSKTRTLKK CCCCCCCCCCHHHHH | 43.12 | 21945579 | |
578 | Acetylation | RLPILPSKTRTLKKQ CCCCCCCCCHHHHHH | 39.83 | 25953088 | |
578 | Ubiquitination | RLPILPSKTRTLKKQ CCCCCCCCCHHHHHH | 39.83 | 29967540 | |
581 | Phosphorylation | ILPSKTRTLKKQVEN CCCCCCHHHHHHHHC | 48.43 | 18691976 | |
581 (in isoform 2) | Phosphorylation | - | 48.43 | - | |
582 (in isoform 2) | Phosphorylation | - | 6.17 | - | |
584 (in isoform 2) | Phosphorylation | - | 63.79 | - | |
595 | Phosphorylation | NKENIEGAQDATENS CCCCCCCCCCCCCCC | 7.41 | 32142685 | |
595 (in isoform 2) | Phosphorylation | - | 7.41 | - | |
597 (in isoform 2) | Phosphorylation | - | 55.73 | - | |
598 (in isoform 2) | Phosphorylation | - | 12.53 | - | |
599 | Phosphorylation | IEGAQDATENSASSL CCCCCCCCCCCHHHC | 43.95 | 18691976 | |
602 | Phosphorylation | AQDATENSASSLAPG CCCCCCCCHHHCCCC | 24.24 | 25159151 | |
604 | Phosphorylation | DATENSASSLAPGFI CCCCCCHHHCCCCHH | 26.21 | 25850435 | |
605 | Phosphorylation | ATENSASSLAPGFIR CCCCCHHHCCCCHHH | 28.41 | 25850435 | |
610 | Phosphorylation | ASSLAPGFIRGAQAS HHHCCCCHHHCHHCC | 3.15 | 32142685 | |
616 | Phosphorylation | GFIRGAQASSGSPAL CHHHCHHCCCCCCCC | 12.72 | 32142685 | |
617 | Phosphorylation | FIRGAQASSGSPALP HHHCHHCCCCCCCCC | 24.13 | 30266825 | |
618 | Phosphorylation | IRGAQASSGSPALPR HHCHHCCCCCCCCCH | 46.43 | 30266825 | |
619 (in isoform 2) | Phosphorylation | - | 34.84 | - | |
620 | Phosphorylation | GAQASSGSPALPRKQ CHHCCCCCCCCCHHH | 14.67 | 19664994 | |
631 | Phosphorylation | PRKQRDKSPSSLLED CHHHCCCCHHHHHHH | 34.01 | 29255136 | |
633 | Phosphorylation | KQRDKSPSSLLEDAK HHCCCCHHHHHHHHH | 40.48 | 29255136 | |
634 | Phosphorylation | QRDKSPSSLLEDAKE HCCCCHHHHHHHHHH | 40.12 | 30266825 | |
634 (in isoform 4) | Phosphorylation | - | 40.12 | 24719451 | |
635 (in isoform 2) | Phosphorylation | - | 7.72 | - | |
642 | Phosphorylation | LLEDAKETCFTRDRK HHHHHHHHHCCCCCC | 16.53 | 24732914 | |
645 | Phosphorylation | DAKETCFTRDRKGGF HHHHHHCCCCCCCCC | 33.53 | 24732914 | |
647 (in isoform 4) | Phosphorylation | - | 54.29 | 28796482 | |
649 (in isoform 7) | Phosphorylation | - | 68.61 | 24719451 | |
654 | Phosphorylation | DRKGGFFSSFMKKRN CCCCCCHHHHHHHCC | 22.02 | 25159151 | |
655 | Phosphorylation | RKGGFFSSFMKKRNA CCCCCHHHHHHHCCC | 24.97 | 28355574 | |
655 (in isoform 10) | Phosphorylation | - | 24.97 | 24719451 | |
659 | Acetylation | FFSSFMKKRNAPTPP CHHHHHHHCCCCCCC | 38.81 | 7678533 | |
662 (in isoform 7) | Phosphorylation | - | 17.24 | 28796482 | |
664 | Phosphorylation | MKKRNAPTPPKRSSS HHHCCCCCCCCCCHH | 50.22 | 21815630 | |
667 | "N6,N6-dimethyllysine" | RNAPTPPKRSSSFRE CCCCCCCCCCHHHHH | 67.14 | - | |
667 | Methylation | RNAPTPPKRSSSFRE CCCCCCCCCCHHHHH | 67.14 | - | |
668 (in isoform 10) | Phosphorylation | - | 47.77 | 28796482 | |
669 | Phosphorylation | APTPPKRSSSFREME CCCCCCCCHHHHHHC | 36.14 | 23403867 | |
670 | Phosphorylation | PTPPKRSSSFREMEN CCCCCCCHHHHHHCC | 37.21 | 23403867 | |
670 | Ubiquitination | PTPPKRSSSFREMEN CCCCCCCHHHHHHCC | 37.21 | 29967540 | |
670 (in isoform 5) | Phosphorylation | - | 37.21 | 24719451 | |
671 | Phosphorylation | TPPKRSSSFREMENQ CCCCCCHHHHHHCCC | 29.57 | 25159151 | |
681 | Phosphorylation | EMENQPHKKYELTGN HHCCCCCCEEECCCC | 64.83 | 33259812 | |
682 (in isoform 2) | Phosphorylation | - | 40.71 | - | |
683 | Phosphorylation | ENQPHKKYELTGNFS CCCCCCEEECCCCCC | 22.45 | 22817900 | |
683 (in isoform 5) | Phosphorylation | - | 22.45 | 28796482 | |
685 | Ubiquitination | QPHKKYELTGNFSSV CCCCEEECCCCCCCC | 7.25 | 29967540 | |
691 | Ubiquitination | ELTGNFSSVASLQHA ECCCCCCCCEEEEEC | 19.98 | 29967540 | |
696 | Phosphorylation | FSSVASLQHADGFSF CCCCEEEEECCCCCC | 27.51 | 33259812 | |
702 | Phosphorylation | LQHADGFSFTPAQQE EEECCCCCCCHHHHH | 33.47 | 33259812 | |
706 | Ubiquitination | DGFSFTPAQQEANLV CCCCCCHHHHHCCCC | 22.19 | 29967540 | |
717 | Phosphorylation | ANLVPPKCYGGSFAQ CCCCCCCCCCCCHHH | 4.75 | 33259812 | |
718 | Phosphorylation | NLVPPKCYGGSFAQR CCCCCCCCCCCHHHC | 30.55 | 27273156 | |
738 | Phosphorylation | DGGGGGGSGTAGGGW CCCCCCCCCCCCCCC | 35.92 | 30576142 | |
745 (in isoform 2) | Phosphorylation | - | 9.17 | - | |
747 (in isoform 2) | Phosphorylation | - | 18.24 | - | |
748 (in isoform 2) | Phosphorylation | - | 2.58 | - | |
749 | Phosphorylation | GGGWSGITGFFTPRL CCCCCCCCCCCCHHH | 31.31 | 30576142 | |
752 (in isoform 2) | Phosphorylation | - | 11.00 | - | |
753 | Phosphorylation | SGITGFFTPRLIKKT CCCCCCCCHHHHHHH | 12.77 | 18691976 | |
753 (in isoform 2) | Phosphorylation | - | 12.77 | - | |
762 | Phosphorylation | RLIKKTLGLRAGKPT HHHHHHHCCCCCCCC | 20.53 | 32645325 | |
768 | Phosphorylation | LGLRAGKPTASDDTS HCCCCCCCCCCCCCC | 32.07 | 32645325 | |
771 | Phosphorylation | RAGKPTASDDTSKPF CCCCCCCCCCCCCCC | 38.20 | 28555341 | |
776 | Acetylation | TASDDTSKPFPRSNS CCCCCCCCCCCCCCC | 53.41 | - | |
779 (in isoform 2) | Phosphorylation | - | 47.52 | - | |
781 | Phosphorylation | TSKPFPRSNSTSSMS CCCCCCCCCCCCCCC | 35.06 | 17525332 | |
781 (in isoform 2) | Phosphorylation | - | 35.06 | - | |
782 (in isoform 2) | Phosphorylation | - | 51.06 | - | |
783 | Phosphorylation | KPFPRSNSTSSMSSG CCCCCCCCCCCCCCC | 30.80 | 23401153 | |
784 | Phosphorylation | PFPRSNSTSSMSSGL CCCCCCCCCCCCCCC | 29.13 | 29255136 | |
784 (in isoform 2) | Phosphorylation | - | 29.13 | - | |
785 | Phosphorylation | FPRSNSTSSMSSGLP CCCCCCCCCCCCCCC | 24.70 | 29255136 | |
786 | Phosphorylation | PRSNSTSSMSSGLPE CCCCCCCCCCCCCCH | 23.83 | 29255136 | |
788 | Phosphorylation | SNSTSSMSSGLPEQD CCCCCCCCCCCCHHH | 24.17 | 28450419 | |
788 | Ubiquitination | SNSTSSMSSGLPEQD CCCCCCCCCCCCHHH | 24.17 | 29967540 | |
789 | Phosphorylation | NSTSSMSSGLPEQDR CCCCCCCCCCCHHHH | 35.39 | 28450419 | |
794 | Ubiquitination | MSSGLPEQDRMAMTL CCCCCCHHHHHHHHC | 41.49 | 29967540 | |
797 | Phosphorylation | GLPEQDRMAMTLPRN CCCHHHHHHHHCCCC | 3.93 | 32142685 | |
799 | Phosphorylation | PEQDRMAMTLPRNCQ CHHHHHHHHCCCCHH | 2.64 | 33259812 | |
800 | Phosphorylation | EQDRMAMTLPRNCQR HHHHHHHHCCCCHHC | 24.87 | 28555341 | |
805 | Phosphorylation | AMTLPRNCQRSKLQL HHHCCCCHHCCHHEE | 3.62 | 33259812 | |
808 | Phosphorylation | LPRNCQRSKLQLERT CCCCHHCCHHEEEEE | 16.31 | 30622161 | |
809 | Ubiquitination | PRNCQRSKLQLERTV CCCHHCCHHEEEEEE | 42.30 | 29967540 | |
812 | Phosphorylation | CQRSKLQLERTVSTS HHCCHHEEEEEECCC | 7.53 | 32142685 | |
815 | Phosphorylation | SKLQLERTVSTSSQP CHHEEEEEECCCCCC | 14.94 | 21955146 | |
817 | Phosphorylation | LQLERTVSTSSQPEE HEEEEEECCCCCCHH | 23.20 | 25159151 | |
818 | Phosphorylation | QLERTVSTSSQPEEN EEEEEECCCCCCHHH | 28.23 | 25159151 | |
818 | Ubiquitination | QLERTVSTSSQPEEN EEEEEECCCCCCHHH | 28.23 | 29967540 | |
819 | Phosphorylation | LERTVSTSSQPEENV EEEEECCCCCCHHHH | 21.33 | 25159151 | |
820 | Phosphorylation | ERTVSTSSQPEENVD EEEECCCCCCHHHHH | 50.25 | 25159151 | |
828 (in isoform 2) | Phosphorylation | - | 30.89 | - | |
833 | Phosphorylation | VDRANDMLPKKSEES HHHHHHCCCCCCHHC | 6.66 | 32142685 | |
833 | Ubiquitination | VDRANDMLPKKSEES HHHHHHCCCCCCHHC | 6.66 | 29967540 | |
839 | Ubiquitination | MLPKKSEESAAPSRE CCCCCCHHCCCCCCC | 53.41 | 29967540 | |
854 | Ubiquitination | RPKAKLLPRGATALP CCCCCCCCCCCCCCC | 42.99 | 29967540 | |
858 | Phosphorylation | KLLPRGATALPLRTP CCCCCCCCCCCCCCC | 31.39 | 29514088 | |
864 | Phosphorylation | ATALPLRTPSGDLAI CCCCCCCCCCCCEEE | 29.50 | 17192257 | |
866 | Phosphorylation | ALPLRTPSGDLAITE CCCCCCCCCCEEEEE | 44.31 | 21815630 | |
872 | Phosphorylation | PSGDLAITEKDPPGV CCCCEEEEECCCCCC | 31.23 | 20068231 | |
879 (in isoform 2) | Phosphorylation | - | 7.41 | - | |
900 (in isoform 2) | Phosphorylation | - | 9.80 | - | |
902 (in isoform 2) | Phosphorylation | - | 17.65 | - | |
915 | Phosphorylation | GEQPGWPSPAKAAPV CCCCCCCCCCCCCCC | 30.86 | 25159151 | |
921 | Phosphorylation | PSPAKAAPVLPTTHN CCCCCCCCCCCCCCC | 32.79 | 32142685 | |
925 | Phosphorylation | KAAPVLPTTHNHKVP CCCCCCCCCCCCCCC | 36.20 | 23312004 | |
926 | Phosphorylation | AAPVLPTTHNHKVPV CCCCCCCCCCCCCCE | 20.81 | 23312004 | |
930 | Phosphorylation | LPTTHNHKVPVLISP CCCCCCCCCCEEECC | 54.26 | 32142685 | |
932 (in isoform 2) | Phosphorylation | - | 21.72 | - | |
936 | Phosphorylation | HKVPVLISPTLKHTP CCCCEEECCCCCCCC | 13.99 | 19664994 | |
936 | Ubiquitination | HKVPVLISPTLKHTP CCCCEEECCCCCCCC | 13.99 | 29967540 | |
938 | Phosphorylation | VPVLISPTLKHTPAD CCEEECCCCCCCCCC | 41.47 | 30266825 | |
942 | Ubiquitination | ISPTLKHTPADVQLI ECCCCCCCCCCEEEE | 20.70 | 29967540 | |
951 | Phosphorylation | ADVQLIGTDSQGNKF CCEEEEEECCCCCEE | 26.03 | 32142685 | |
953 | Phosphorylation | VQLIGTDSQGNKFKL EEEEEECCCCCEEEE | 39.56 | 25627689 | |
957 | Methylation | GTDSQGNKFKLLSEH EECCCCCEEEEEEEC | 51.18 | - | |
957 | Ubiquitination | GTDSQGNKFKLLSEH EECCCCCEEEEEEEC | 51.18 | 29967540 | |
959 | Methylation | DSQGNKFKLLSEHQV CCCCCEEEEEEECCC | 50.56 | - | |
962 | Phosphorylation | GNKFKLLSEHQVTSS CCEEEEEEECCCCCC | 43.39 | 27174698 | |
967 | Phosphorylation | LLSEHQVTSSGDKDR EEEECCCCCCCCCCC | 15.59 | 27174698 | |
968 | Phosphorylation | LSEHQVTSSGDKDRP EEECCCCCCCCCCCC | 33.20 | 18691976 | |
969 | Phosphorylation | SEHQVTSSGDKDRPR EECCCCCCCCCCCCC | 41.46 | 25159151 | |
981 | Acetylation | RPRRVKPKCAPPPPP CCCCCCCCCCCCCCC | 36.99 | 30586989 | |
997 | Phosphorylation | MRLLQHPSICSDPTE HHHHCCCCCCCCCCC | 33.82 | 25159151 | |
1000 | Phosphorylation | LQHPSICSDPTEEPT HCCCCCCCCCCCCCC | 44.98 | 25159151 | |
1003 | Phosphorylation | PSICSDPTEEPTALT CCCCCCCCCCCCCCC | 58.95 | 23312004 | |
1014 (in isoform 2) | Phosphorylation | - | 32.74 | - | |
1018 (in isoform 2) | Phosphorylation | - | 31.52 | - | |
1023 | Acetylation | SETQEGGKKAALGAV CCCCCCCCEEEEECC | 50.53 | 26051181 | |
1033 | Phosphorylation | ALGAVPISGKAGRPV EEECCCCCCCCCCCC | 28.33 | 32142685 | |
1039 | Phosphorylation | ISGKAGRPVMPPPQV CCCCCCCCCCCCCCC | 26.33 | 32142685 | |
1050 | Phosphorylation | PPQVPLPTSSISPAK CCCCCCCCCCCCHHH | 42.67 | 25159151 | |
1051 | Phosphorylation | PQVPLPTSSISPAKM CCCCCCCCCCCHHHC | 24.59 | 30576142 | |
1052 | Phosphorylation | QVPLPTSSISPAKMA CCCCCCCCCCHHHCC | 29.57 | 30576142 | |
1054 | Phosphorylation | PLPTSSISPAKMANG CCCCCCCCHHHCCCC | 22.28 | 25159151 | |
1057 | Methylation | TSSISPAKMANGTAG CCCCCHHHCCCCCCC | 41.76 | - | |
1066 | Methylation | ANGTAGTKVALRKTK CCCCCCCHHHHHHHH | 25.29 | - | |
1072 | Phosphorylation | TKVALRKTKQAAEKI CHHHHHHHHHHHHHC | 23.19 | 29396449 | |
1107 | Phosphorylation | LTEPVPNSQLVDTGH HCCCCCCHHHCCCHH | 20.87 | - | |
1112 | Phosphorylation | PNSQLVDTGHQLLDY CCHHHCCCHHHHHHH | 29.14 | - |
Modified Location | Modified Residue | Modification | Type of Upstream Proteins | Gene Name of Upstream Proteins | UniProt AC of Upstream Proteins | Sources |
---|---|---|---|---|---|---|
116 | Y | Phosphorylation | Kinase | LYN | P07948 | GPS |
116 | Y | Phosphorylation | Kinase | HCK | P08631 | GPS |
116 | Y | Phosphorylation | Kinase | FYN | P06241 | GPS |
139 | Y | Phosphorylation | Kinase | PDGFRB | P09619 | PSP |
161 | Y | Phosphorylation | Kinase | PDGFRB | P09619 | PSP |
161 | Y | Phosphorylation | Kinase | LYN | P07948 | GPS |
161 | Y | Phosphorylation | Kinase | HCK | P08631 | GPS |
161 | Y | Phosphorylation | Kinase | FYN | P06241 | GPS |
174 | Y | Phosphorylation | Kinase | HCK | P08631 | GPS |
174 | Y | Phosphorylation | Kinase | LYN | P07948 | GPS |
174 | Y | Phosphorylation | Kinase | FYN | P06241 | GPS |
185 | Y | Phosphorylation | Kinase | FYN | P06241 | GPS |
185 | Y | Phosphorylation | Kinase | HCK | P08631 | GPS |
185 | Y | Phosphorylation | Kinase | LYN | P07948 | GPS |
218 | Y | Phosphorylation | Kinase | FYN | P06241 | GPS |
218 | Y | Phosphorylation | Kinase | HCK | P08631 | GPS |
218 | Y | Phosphorylation | Kinase | LYN | P07948 | GPS |
231 | Y | Phosphorylation | Kinase | FYN | P06241 | GPS |
231 | Y | Phosphorylation | Kinase | HCK | P08631 | GPS |
231 | Y | Phosphorylation | Kinase | LYN | P07948 | GPS |
261 | Y | Phosphorylation | Kinase | LYN | P07948 | GPS |
261 | Y | Phosphorylation | Kinase | ABL2 | P42684 | GPS |
261 | Y | Phosphorylation | Kinase | HCK | P08631 | GPS |
261 | Y | Phosphorylation | Kinase | FYN | P06241 | GPS |
261 | Y | Phosphorylation | Kinase | ABL | P00519 | PSP |
272 | Y | Phosphorylation | Kinase | PDGFRB | P09619 | PSP |
439 | Y | Phosphorylation | Kinase | ABL2 | P42684 | GPS |
439 | Y | Phosphorylation | Kinase | SRC-TYPE TYR-KINASES | - | Uniprot |
Modified Location | Modified Residue | Modification | Function | Reference | ||
---|---|---|---|---|---|---|
Oops, there are no descriptions of PTM sites of ABL2_HUMAN !! |
* Distance = the distance between SAP position and PTM sites.
Modified Location | Modification | Variant Position (Distance <= 10) |
Residue Change | SAP | Related Disease | Reference |
---|---|---|---|---|---|---|
Oops, there are no SNP-PTM records of ABL2_HUMAN !! |
Interacting Protein | Gene Name | Interaction Type | PPI Reference | Domain-Domain Interactions |
---|---|---|---|---|
ABL1_HUMAN | ABL1 | physical | 12569093 | |
CATA_HUMAN | CAT | physical | 12777400 | |
SRBS2_HUMAN | SORBS2 | physical | 9211900 | |
PSA7_HUMAN | PSMA7 | physical | 16678104 | |
ERBB4_HUMAN | ERBB4 | physical | 16273093 | |
FBX38_HUMAN | FBXO38 | physical | 21988832 | |
HCK_HUMAN | HCK | physical | 21988832 | |
TPD53_HUMAN | TPD52L1 | physical | 21988832 | |
NMES1_HUMAN | C15orf48 | physical | 21988832 | |
MS18B_HUMAN | OIP5 | physical | 21988832 | |
GPX1_HUMAN | GPX1 | physical | 12893824 | |
CIP4_HUMAN | TRIP10 | physical | 18330356 | |
ABL2_HUMAN | ABL2 | physical | 15735735 | |
CRK_HUMAN | CRK | physical | 8194526 | |
GRB2_HUMAN | GRB2 | physical | 8194526 | |
RIN1_HUMAN | RIN1 | physical | 15886098 | |
ABL2_HUMAN | ABL2 | physical | 15886098 | |
CRK_CHICK | CRK | physical | 15886098 | |
CRK_HUMAN | CRK | physical | 15886098 | |
RASH_HUMAN | HRAS | physical | 15886098 | |
MDM2_HUMAN | MDM2 | physical | 25624478 | |
P55G_HUMAN | PIK3R3 | physical | 25814554 |
Kegg Disease | ||||||
---|---|---|---|---|---|---|
There are no disease associations of PTM sites. | ||||||
OMIM Disease | ||||||
There are no disease associations of PTM sites. | ||||||
Kegg Drug | ||||||
There are no disease associations of PTM sites. | ||||||
DrugBank | ||||||
There are no disease associations of PTM sites. |
loading...
Phosphorylation | |
Reference | PubMed |
"Quantitative phosphoproteomic analysis of T cell receptor signalingreveals system-wide modulation of protein-protein interactions."; Mayya V., Lundgren D.H., Hwang S.-I., Rezaul K., Wu L., Eng J.K.,Rodionov V., Han D.K.; Sci. Signal. 2:RA46-RA46(2009). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-817; SER-820 ANDSER-936, AND MASS SPECTROMETRY. | |
"Large-scale proteomics analysis of the human kinome."; Oppermann F.S., Gnad F., Olsen J.V., Hornberger R., Greff Z., Keri G.,Mann M., Daub H.; Mol. Cell. Proteomics 8:1751-1764(2009). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-96; SER-620; SER-631;TYR-683; TYR-718; SER-781; THR-784; THR-815; SER-817; SER-819; SER-820AND SER-936, AND MASS SPECTROMETRY. | |
"Lys-N and trypsin cover complementary parts of the phosphoproteome ina refined SCX-based approach."; Gauci S., Helbig A.O., Slijper M., Krijgsveld J., Heck A.J.,Mohammed S.; Anal. Chem. 81:4493-4501(2009). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-620; SER-631; SER-783;SER-817; THR-818; SER-819; SER-820; SER-936 AND THR-938, AND MASSSPECTROMETRY. | |
"A quantitative atlas of mitotic phosphorylation."; Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E.,Elledge S.J., Gygi S.P.; Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-620; SER-631; SER-633;SER-655; SER-817; SER-820; SER-915 AND SER-936, AND MASS SPECTROMETRY. | |
"Kinase-selective enrichment enables quantitative phosphoproteomics ofthe kinome across the cell cycle."; Daub H., Olsen J.V., Bairlein M., Gnad F., Oppermann F.S., Korner R.,Greff Z., Keri G., Stemmann O., Mann M.; Mol. Cell 31:438-448(2008). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT TYR-116; SER-203; TYR-231;SER-275; SER-602; SER-620; SER-631; SER-671; TYR-718; SER-820;THR-864; SER-915 AND SER-936, AND MASS SPECTROMETRY. | |
"Combining protein-based IMAC, peptide-based IMAC, and MudPIT forefficient phosphoproteomic analysis."; Cantin G.T., Yi W., Lu B., Park S.K., Xu T., Lee J.-D.,Yates J.R. III; J. Proteome Res. 7:1346-1351(2008). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-71, AND MASSSPECTROMETRY. | |
"Automated phosphoproteome analysis for cultured cancer cells by two-dimensional nanoLC-MS using a calcined titania/C18 biphasic column."; Imami K., Sugiyama N., Kyono Y., Tomita M., Ishihama Y.; Anal. Sci. 24:161-166(2008). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-203, AND MASSSPECTROMETRY. | |
"ATM and ATR substrate analysis reveals extensive protein networksresponsive to DNA damage."; Matsuoka S., Ballif B.A., Smogorzewska A., McDonald E.R. III,Hurov K.E., Luo J., Bakalarski C.E., Zhao Z., Solimini N.,Lerenthal Y., Shiloh Y., Gygi S.P., Elledge S.J.; Science 316:1160-1166(2007). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-817 AND SER-820, ANDMASS SPECTROMETRY. | |
"Proteomics analysis of protein kinases by target class-selectiveprefractionation and tandem mass spectrometry."; Wissing J., Jaensch L., Nimtz M., Dieterich G., Hornberger R.,Keri G., Wehland J., Daub H.; Mol. Cell. Proteomics 6:537-547(2007). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-631; SER-783; SER-817AND SER-936, AND MASS SPECTROMETRY. | |
"Global, in vivo, and site-specific phosphorylation dynamics insignaling networks."; Olsen J.V., Blagoev B., Gnad F., Macek B., Kumar C., Mortensen P.,Mann M.; Cell 127:635-648(2006). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-203 AND SER-631, ANDMASS SPECTROMETRY. | |
"Profiling of tyrosine phosphorylation pathways in human cells usingmass spectrometry."; Salomon A.R., Ficarro S.B., Brill L.M., Brinker A., Phung Q.T.,Ericson C., Sauer K., Brock A., Horn D.M., Schultz P.G., Peters E.C.; Proc. Natl. Acad. Sci. U.S.A. 100:443-448(2003). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT TYR-310; TYR-439; THR-440AND TYR-515, AND MASS SPECTROMETRY. | |
"An extensive survey of tyrosine phosphorylation revealing new sitesin human mammary epithelial cells."; Heibeck T.H., Ding S.-J., Opresko L.K., Zhao R., Schepmoes A.A.,Yang F., Tolmachev A.V., Monroe M.E., Camp D.G. II, Smith R.D.,Wiley H.S., Qian W.-J.; J. Proteome Res. 8:3852-3861(2009). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT TYR-439, AND MASSSPECTROMETRY. | |
"Global survey of phosphotyrosine signaling identifies oncogenickinases in lung cancer."; Rikova K., Guo A., Zeng Q., Possemato A., Yu J., Haack H., Nardone J.,Lee K., Reeves C., Li Y., Hu Y., Tan Z., Stokes M., Sullivan L.,Mitchell J., Wetzel R., Macneill J., Ren J.M., Yuan J.,Bakalarski C.E., Villen J., Kornhauser J.M., Smith B., Li D., Zhou X.,Gygi S.P., Gu T.-L., Polakiewicz R.D., Rush J., Comb M.J.; Cell 131:1190-1203(2007). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT TYR-439, AND MASSSPECTROMETRY. | |
"Ubiquitination and degradation of the Arg tyrosine kinase isregulated by oxidative stress."; Cao C., Li Y., Leng Y., Li P., Ma Q., Kufe D.; Oncogene 24:2433-2440(2005). Cited for: FUNCTION, PHOSPHORYLATION AT TYR-261, AND UBIQUITINATION. | |
"Two distinct phosphorylation pathways have additive effects on Ablfamily kinase activation."; Tanis K.Q., Veach D., Duewel H.S., Bornmann W.G., Koleske A.J.; Mol. Cell. Biol. 23:3884-3896(2003). Cited for: AUTOPHOSPHORYLATION AT TYR-272; TYR-439; TYR-568 AND TYR-683, ANDENZYME REGULATION. |